Schwarz R, Krüll A, Baumann M, Zornig C, Wiegel T, Weh H J
Abteilung für Strahlentherapie, Universitätskrankenhaus Hamburg-Eppendorf.
Strahlenther Onkol. 1996 Feb;172(2):64-73.
Published data for radiotherapy in soft tissue sarcomas refer in most of the cases to the use of irradiation for primary tumors. Experiences of radiotherapy in local recurrences are limited. The own treatment results of a multimodal treatment approach in a large number of patients will be analyzed for local tumor control rates, survival rates, side effects and prognostic factors and will be compared to the literature.
At the University Hospital Hamburg-Eppendorf a total of 98 patients with local recurrences of soft tissue sarcomas were irradiated between 1980 and 1993. The median age of the patients was 55 years. There was a large variety of different histologies. Grading was evaluable in 95 cases: G1 24 patients, G2 21 patients and G3 50 patients. Localisation was dominated by the extremities with 64.3%. Recurrences were reclassified: 21 patients had rT1-tumors and 77 patients had rT2-tumors. Twelve cases showed lymph node metastases and 9 patients distant metastases. Generally treatment included surgery and postoperative irradiation. R-classification showed R0 in 25, R1 in 20 and R2 in 48 cases. Neutrontherapy was prefered in 57 cases and neutron- and photontherapy in 22 cases. Local tumor control rates and survival rates were calculated using the Kaplan-Meier method. Side effects were scored using the RTOG/EORTC scoring system. Univariate and multivariate analyses were applied to evaluate prognostic factors.
Local tumor control rates at 5 years were 56.4%, for G1 75.2%, G2 52.5%, G3 47.1%, rT1 66.0%, rT2 53.6%, R0 63.4%, R1 42.3% and R2 53.2%, N0 61.1% vs. N1 31.7%. Survival rates at 5 years were 45.2%, for G1 64.8%, G2 66.9%, G3 25.0%, rT1 60.0%, rT2 41.5%, R0 64.2%, R1 49.3% and R2 32.7%. Acute side effects were scored as grade 1 and grade 2. The rate of grade 3 and 4 late effects was about 6%. Lymph node status was a significant factor for local control. Grade, residual tumor status, type of irradiation and the applied neutron dose were significant factors for survival.
Nowadays no standard treatment exists for local recurrences of soft tissue sarcomas. Treatment should be interdisciplinary. Local recurrences should be avoided by the consequent use of surgery and radiotherapy. It is important that local recurrences should be detected early. Neutrontherapy may bring advantages for local control of recurrences with macroscopic tumor residuals.
软组织肉瘤放疗的已发表数据在大多数情况下涉及对原发性肿瘤的照射。局部复发的放疗经验有限。将分析大量患者采用多模式治疗方法的自身治疗结果,以了解局部肿瘤控制率、生存率、副作用和预后因素,并与文献进行比较。
1980年至1993年间,汉堡-埃彭多夫大学医院共对98例软组织肉瘤局部复发患者进行了放疗。患者的中位年龄为55岁。组织学类型多种多样。95例可进行分级:G1级24例,G2级21例,G3级50例。64.3%的复发位于四肢。复发情况重新分类:21例为rT1期肿瘤,77例为rT2期肿瘤。12例出现淋巴结转移,9例出现远处转移。一般治疗包括手术和术后放疗。R分级显示,25例为R0,20例为R1,48例为R2。57例优先采用中子治疗,22例采用中子和光子联合治疗。采用Kaplan-Meier法计算局部肿瘤控制率和生存率。使用RTOG/EORTC评分系统对副作用进行评分。应用单因素和多因素分析评估预后因素。
5年局部肿瘤控制率为56.4%,G1级为75.2%,G2级为52.5%,G3级为47.1%,rT1期为66.0%,rT2期为53.6%,R0为63.4%,R1为42.3%,R2为53.2%,N0为61.1%,N1为31.7%。5年生存率为45.2%,G1级为64.8%,G2级为66.9%,G3级为25.0%,rT1期为60.0%,rT2期为41.5%,R0为64.2%,R